Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-03

Clinical Trial Update: Bupropion for ADHD in Adolescents With Substance Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update on bupropion for adolescents with ADHD and substance use disorders, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Attention Deficit Hyperactivity Disorder, Nicotine Dependence | Phase 4 | Status: COMPLETED | Results posted: 2019-12-03